ArticleInternational journal of chronic obstructive pulmonary disease2026
Effective-Component Compatibility of Bufei Yishen Formula Alleviates Alveolar Epithelial Barrier Damage in COPD Through Inhibition of p38 MAPK Phosphorylation.
Xuejie Shao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.